GNX-5086

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGNX-5086
Drug Alias NameGNX-5086
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitocliondrial permeability transition pore inhibitors
TargetsMitocliondrial permeability transition pore
Therapy Area/IndicationsMyocardial Reperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenextra
China Registration ClassN/A

Develop Information

Active CompaniesGenextra
Inactive CompaniesN/A
Active IndicationsMyocardial Reperfusion Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A